Servier

Objectives

Identify promising early-stage pharmaceutical R&Dinnovation projects within China’s life sciencesecosystem
Explore innovative collaboration and partneringopportunities
Support Servier China’s 2030 R&D Strategy

Participants

Biotech companies and start-ups in Greater China
Universities, research institutes, and medical institutions

Scope of Proposal

We welcome innovative early-stage proposals in:

Precision medicine programs in oncology and neuroscience
Novel therapeutic modalities and platform technologies
Drug discovery and development enabling technologies, including Al and digital applications

Learn More: https://servier.com/en/partnering/

Submission Requirements

Materials Required

Non-confidential project summary and presentation slides
Clear highlights of key innovations

Language

English

Timeline

Mid-July: Applications open
End of August: Submission deadline
Mid-October: Shortlist notification
Early November: Final roadshow / pitch day

Winner Award & Opportunities

RMB 800,000 award to support access to ATLATL turnkey R&D facilities and services
Opportunity to connect with senior scientists from Servier Global R&D for potential future collaboration
Invitation to present at Servier China R&D Day or other joint events organized by Servier and ATLATL

Contact Us